logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most?

Investing in Psychedelic Stocks: A New Frontier in Mental Health Treatment

Oct 6, 2025

Life Science

考验与机遇:联合健康能否凭财报扭转颓势?

Trials and Opportunities: Can UnitedHealth Reverse Its Decline with Its Financial Report?

Oct 4, 2025

Life Science

以定价权与创新,美敦力构筑通胀护城河

With Pricing Power and Innovation, Medtronic Builds an Inflation Moat

Oct 3, 2025

Life Science

RVMD’s Near-100% Year-To-Date Rally Sparks Valuation Debate: Has the Stock Gotten Too Pricy?

Can AngioDynamics Keep Rising Without Making Money?

Oct 2, 2025

Life Science

跟随木头姐买入?她近期增持了这三只股票

Follow Cathie Wood’s Lead? She Recently Increased Holdings in These Three Stocks

Oct 1, 2025

Life Science, Technology

AI驱动未来医疗,BioNTech股价应声上涨近4%

AI Drives Future Healthcare, BioNTech Stock Rises Nearly 4% in Response

Oct 1, 2025

Life Science

为何艾伯维当前是投资者的不错选择?

Why AbbVie Is Currently a Good Choice for Investors?

Oct 1, 2025

Life Science

如何通过一只ETF投资整个生物技术行业?

How to Invest in the Entire Biotechnology Industry Through One ETF?

Oct 1, 2025

Life Science

CVS Health Surges Over 25% Year-to-Date: Why Analysts Keep Lifting Its Price Targets

Pfizer Soars on Landmark Deal with Trump Administration to Cut Drug Prices

Oct 1, 2025

Life Science

医疗保健股冰火两重天:一支潜力股与两支需观察的股票

Healthcare Stocks: One Promising Stock and Two to Watch

Sep 29, 2025

Life Science

辉瑞巨资收购Metsera,重塑减肥药赛道的关键布局

Pfizer’s Multi-Billion Dollar Acquisition of Metsera: A Key Move to Reshape the Weight-Loss Drug Landscape

Sep 26, 2025

Life Science

AbbVie's $600 Billion Bet: Growth and Dividends After Humira

AbbVie’s $600 Billion Bet: Growth and Dividends After Humira

Sep 25, 2025

Life Science

辉瑞收购Metsera,Viking Therapeutics前景引关注

Pfizer Acquires Metsera, Viking Therapeutics’ Prospects Attract Attention

Sep 25, 2025

Life Science

跌出来的机会?剖析诺和诺德的三大基本面支撑

Opportunities from the Dip? Analyzing Novo Nordisk’s Three Fundamental Pillars

Sep 25, 2025

Life Science

豪掷50亿!揭秘礼来继减肥针后的下一个增长引擎

Splashing Out 5 Billion! Unveiling Lilly’s Next Growth Engine After the Weight-Loss Injection

Sep 24, 2025

Life Science

在研药物试验结果积极,Atai Life Sciences股价应声飙升

Positive Results from Investigational Drug Trial, Atai Life Sciences Stock Soars Accordingly

Sep 23, 2025

Life Science

Pfizer Challenges Novo Nordisk and Eli Lilly with $7.3B Metsera Buyout

Pfizer Challenges Novo Nordisk and Eli Lilly with $7.3B Metsera Buyout

Sep 23, 2025

Life Science

监管利好与分析师看好,BioNTech股价双喜临门

Regulatory Tailwinds and Analyst Optimism: A Double Dose of Good News for BioNTech’s Stock

Sep 23, 2025

Life Science

  • ‹‹ Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada